STOCKHOLDERS' EQUITY |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS' EQUITY | 4. STOCKHOLDERS' EQUITY
In February 2025 options to purchase 88,500 shares of our common stock were exercised at a price of $ per share for total proceeds of $336,300. Our president and CEO exercised options, and 2 directors exercised options each. EDCO Partners, LLLP, of which our CFO and board chairman is the general partner provided $132,240 to enable 19 option holders to exercise and simultaneously sell their shares to EDCO Partners, to be held on behalf of certain of its limited partners, including a third director and an entity controlled by our CFO and board chairman. There was no intrinsic value on the exercised options. At March 31, 2025 options remained outstanding with a weighted average life of years. All of these options were fully vested.
The options outstanding at March 31, 2025 had an intrinsic value of $.
At March 31, 2025 there were 68,750 warrants outstanding, all with an exercise price of $4.50 and all expiring December 31, 2030. There were 62,500 warrants outstanding at December 31, 2024.
|